Severe Malaria

Manifestations, diagnosis, chemotherapy, and management of severe malaria in adults
  • Lucille Blumberg
Part of the Perspective on Critical Care Infectious Diseases book series (CCID, volume 9)


Human Immunodeficiency Virus Disseminate Intravascular Coagulation Falciparum Malaria Severe Malaria Cerebral Malaria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002; 415: 670–672.PubMedCrossRefGoogle Scholar
  2. 2.
    Marsh K. Malaria disaster in Africa. Lancet 1998; 352: 924–925.PubMedCrossRefGoogle Scholar
  3. 3.
    Baird JK. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 1998; 92: 367–390.PubMedCrossRefGoogle Scholar
  4. 4.
    World Health Organization (2000). Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1): S1/1–S1/90.Google Scholar
  5. 5.
    Trape JF, Pison G, Preziosi MP, et al. Impact of chloroqine resistance on malaria mortality. C R Acad Sci Paris Serie III 1998; 321:689–697.Google Scholar
  6. 6.
    Durrheim DN, Frieremans S, Kruger P, et al. Confidential inquiry into malaria deaths. Bull WHO 1999; 77: 263–266.PubMedGoogle Scholar
  7. 7.
    Miller LH, Baruch DI, Marsh K. The pathogenic basis of malaria. Nature 2002; 415:673–679.PubMedCrossRefGoogle Scholar
  8. 8.
    Chotivanich K, Udomsangpetch R, Simpson JA, et al. Parasite multiplication potential and the severity of falciparum malaria. J Infect Dis 2000; 181:1206–1209.PubMedCrossRefGoogle Scholar
  9. 9.
    Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria? Parasitol Today, 1991; 7: 277–280.PubMedCrossRefGoogle Scholar
  10. 10.
    Day NP, Hien TT, Schollaardt T, et al. The prognostic and pathophysiologic role of pro-and anti-inflammatory cytokines in severe malaria. J Infect Dis 1999; 180: 1288–1297.PubMedCrossRefGoogle Scholar
  11. 11.
    White NJ. The treatment of malaria. New Engl J Med 1996; 335: 800–806.PubMedCrossRefGoogle Scholar
  12. 12.
    Field JW. Blood examination and prognosis in acute falciparum malaria. Trans R Soc Trop Med Hyg 1949; 43: 33–48.PubMedGoogle Scholar
  13. 13.
    Phu NH, Day NPJ, Piep PT, et al. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 1995; 89: 200–204.CrossRefGoogle Scholar
  14. 14.
    Beadle C, Long GW, Weiss WR, et al. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 1994; 343: 564–567.PubMedCrossRefGoogle Scholar
  15. 15.
    Isaäcson M, Frean JA. African malaria vector in European aircraft. Lancet 2001; 357: 235.PubMedGoogle Scholar
  16. 16.
    White NJ, Looareesuwan S, Warrell DA, et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983; 32: 1–5.PubMedGoogle Scholar
  17. 17.
    Viriyayudhakorn S, Thitiarchakul S, Nachaisit S, et al. Pharmacokinetics of quinine in obesity. Trans R Soc Trop Med Hyg 2000; 94: 425–428.PubMedCrossRefGoogle Scholar
  18. 18.
    Kremsner P, Winkler S, Brandts C, et al. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 1994; 169: 467–470.PubMedGoogle Scholar
  19. 19.
    White NJ, Looareesuwan S, Warrell DA, et al. Quinine. Pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982; 73: 564–557.PubMedCrossRefGoogle Scholar
  20. 20.
    Silamut K, Molunto P, Ho M, et al. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol 1991; 32: 311–315.PubMedGoogle Scholar
  21. 21.
    Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum malaria in late pregnancy. Lancet 1985; ii: 4–8.Google Scholar
  22. 22.
    Touze J-E, Heno P, Fourcade L, et al. The effects of antimalarial drugs on ventricular repolarization. Am J Trop Med Hyg 2002; 67:54–60.PubMedGoogle Scholar
  23. 23.
    Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. New Engl J Med 1989; 321: 65–70.PubMedGoogle Scholar
  24. 24.
    Hien TT. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Soc Trop Med Hyg 1994; 88(Suppl 1): S7–S8.PubMedGoogle Scholar
  25. 25.
    Looareesuwan S. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 1994; 88(Suppl 1): S9–S11.PubMedGoogle Scholar
  26. 26.
    White NJ, Olliaro P. Strategies for the prevention of antimalarial drug resistance: rationale for combination therapy for malaria. Parasitol Today 1996; 12: 399–401.PubMedGoogle Scholar
  27. 27.
    Murphy SA, Mberu E, Muhia D, et al. The disposition of intramuscular artemether in children with cerebral malaria: a preliminary study. Trans Royal Soc Trop Med Hyg 1997; 91: 331–334.CrossRefGoogle Scholar
  28. 28.
    Hien TT, Phy NH, Mai NTH, et al. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria. Trans R Soc Trop Med Hyg 1992; 84: 584–585.Google Scholar
  29. 29.
    The Artemether-Quinine Meta-Analysis Study Group A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 2001; 95: 637–650.Google Scholar
  30. 30.
    Hien TT, Day NPJ, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. New Engl J Med 1996; 335: 76–83.CrossRefGoogle Scholar
  31. 31.
    Weatherall DJ, Abdalla S. The anaemia of falciparum malaria. Br Med Bull 1982; 38: 147–151.PubMedGoogle Scholar
  32. 32.
    Looareesuwan S, Warrell DA, White NJ. Do patients with cerebral malaria have cerebral oedema? A computer tomography study. Lancet 1983; i: 434–437.Google Scholar
  33. 33.
    Looareesuwan S, Wilairatana P, Kriohna S. Magetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis 1995; 21: 300–309.PubMedGoogle Scholar
  34. 34.
    Warrell DA, Looareesuwan S, Warrell MJ. Dexamethsaone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. New Eng J Med 1982; 306: 313–319.PubMedGoogle Scholar
  35. 35.
    Crawley J, Waruiru C, Mithwani S, et al. Phenobarbitone prophylaxis in childhood cerebral malaria: Final results of a randomized, controlled intervention study. Proc Multilateral Initiative on Malaria Conference, South Africa, 1999.Google Scholar
  36. 36.
    Gordeuk V, Thuma P, Brittenham G, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. New Engl J Med 1992; 327: 1473–1477.PubMedCrossRefGoogle Scholar
  37. 37.
    Day NPJ, Phu NH, Loc PP. Malaria and acute renal failure. J R Coll Physicians Lond 1997; 31: 146–148.PubMedGoogle Scholar
  38. 38.
    Tran TT, Phu NH, Vinh H. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 1992; 15: 874–880.Google Scholar
  39. 39.
    James MFM. Pulmonary damage associated with falciparum malaria. A report of ten cases. Ann Trop Med Parsitol 1985; 79: 123–138.Google Scholar
  40. 40.
    Brody MG, Kiel FW, Sheehy TW, et al. Acute pulmonary oedema in falciparum malaria. New Engl J Med 1968; 279:732–737.CrossRefGoogle Scholar
  41. 41.
    Day NP, Phy NH, Mai NT, et al. The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med 2000; 28: 1833–1840.PubMedGoogle Scholar
  42. 42.
    Tran TH, Day NP, Ly VC. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis 1996; 23: 1274–1281.PubMedGoogle Scholar
  43. 43.
    White NJ. Pathophysiology. Clinics in Tropical Medicine and Communicable Diseases 1986; 1: 55–90.Google Scholar
  44. 44.
    Tanios MA, Kogelman L, McGovern B, Hassoun PM. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit Care Med 2001; 29: 665–667.PubMedGoogle Scholar
  45. 45.
    Beg MA, Khan R, Baig SM, et al. Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg 2002; 67: 230–232.PubMedGoogle Scholar
  46. 46.
    Whitworth J, Morgan D, Quigley M, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356: 1051–1056.PubMedCrossRefGoogle Scholar
  47. 47.
    French N, Gilks CF. Fresh from the field: some controversies in tropical medicine and hygiene. HIV and malaria, do they interact? Trans R Soc Trop Med Hyg 2000; 94: 233–237.PubMedCrossRefGoogle Scholar
  48. 48.
    Cohen C, Karstaedt A, Govender N. Increase in severe malaria in HIV-positive adults in South Africa. XIV International AIDS Conference, Barcelona, 2002.Google Scholar
  49. 49.
    Burchard GD, Kröger J, Knobloch J, et al. Exchange blood transfusion in severe falciparum malaria: retrospective evaluation of 61 patients treated with, compared to 63 patients treated without, exchange transfusion. Trop Med Internal Health 1997; 2:733–740.Google Scholar
  50. 50.
    Phillips P, Nantel S, Benny WB. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: Case report and review. Rev Infect Dis 1990; 12: 1100–1108.PubMedGoogle Scholar
  51. 51.
    Riddle MS, Jackson JL, Sanders JW. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: A meta-analysis. Clin Infect Dis 2002; 34: 1192–98.PubMedCrossRefGoogle Scholar
  52. 52.
    White NJ. What is the future of exchange transfusion in severe malaria? J Infect 1999; 39: 185–186.PubMedCrossRefGoogle Scholar
  53. 53.
    Blumberg L, Lee RP, Lipman J, et al. Predictors of mortality in severe malaria: A two-year experience in a non-endemic area. Anaesth Intens Care 1996; 24: 217–223.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Lucille Blumberg
    • 1
  1. 1.National Institute for Communicable DiseasesSouth Africa

Personalised recommendations